Molecules 2020, 25, 789
11 of 21
1H, 3-H), 7.52–7.49 (m, 1H, 60-H), 7.35–7.30 (m, 2H, 3000-H), 7.26–7.21 (m, 3H, 2000-H and 4000-H), 6.91
t, J = 55.5 Hz, 1H, CF2
), 6.92–6.88 (m, 1H, 50-H), 6.26 (d, J = 15.5 Hz, 1H, 2-H), 5.74 (t, J = 5.3 Hz, 1H,
), 3.88 (s, 3H, C
3O), 3.66 (td, J = 6.9, 5.4 Hz, 2H, 100-H), 2.89 (t, J = 6.9 Hz, 2H, 200-H); 13C-NMR
(CDCl3)
: 166.0 (1-C), 158.3 (t, JCF = 5.6 Hz, 40-C), 139.9 (3-C), 139.0 (1000-C), 132.4 (60-C), 128.9 (2000-C),
128.8 (3000-C), 127.7 (10-C), 126.7 (4000-C), 125.1 (t, JCF = 5.9 Hz, 20-C), 123.2 (t, JCF = 22.2 Hz, 30-C), 119.6
(
H
N
H
H
δ
(2-C), 111.3 (t, JCF = 236.3 Hz, C C
F2H), 111.3 (50-C), 56.0 ( H3O), 40.9 (100-C), 35.8 (200-C). EIMS m/z (%):
331 (34, M+), 226 (32), 211 (100), 183 (19), 132 (16), 104 (17), 91 (47). Analysis for C19H19F2NO2: Calcd
C, 68.87; H, 5.78; N, 4.23%. Found: C, 68.86; H, 5.83; N, 4.10%.
3.2.10. N-Methoxy-N-methyl-3-[3-(difluoromethyl)-4-methoxyphenyl]-(E)-propenamide (11h)
Compound 11h was prepared from acid
9
(30.0 mg, 0.145 mmol), Deoxofluor® 50% in
toluene (0.107 mL, 0.435 mmol), N,O-dimethylhydroxylamine hydrochloride (0.043 g, 0.435 mmol),
and triethylamine (0.082 mL, 0.580 mmol) following the procedure used for 11b. Compound 11h was
obtained as a crystalline white solid (0.026 g, 66%); m.p. 101 ◦C; 1H-NMR (CDCl3)
δ
: 7.83–7.80 (m, 1H,
20-H), 7.69 (d, J = 15.8 Hz, 1H, 3-H), 7.62–7.58 (m, 1H, 60-H), 6.96 (d, J = 15.8 Hz, 1H, 2-H), 6.96–6.93
(m, 1H, 50-H), 6.94 (t, J = 55.5 Hz, 1H, CF2
), 3.91 (s, 3H, C 3OAr), 3.78 (s, 3H, N(CH3)OC 3), 3.31 (s,
3H, N(C
3)OCH3); 13C-NMR (CDCl3) : 167.1 (1-C), 158.5 (t, JCF = 5.7 Hz, 40-C), 142.4 (3-C), 132.7
(60-C), 128.1 (10-C), 125.5 (t, JCF = 5.9 Hz, 20-C), 123.3 (t, JCF = 22.1 Hz, 30-C), 114.8 (2-C), 111.4 (t, JCF
H
H
H
H
δ
=
236.3 Hz, C CH3), 56.0 (CH3OAr), 32.7 (N(CH3)OCH3). EIMS m/z
F2H), 111.3 (50-C), 62.1 (N(CH3)O
(%): 271 (3.4, M+), 211 (100), 183 (18), 132 (12). Analysis for C13H15F2NO3: Calcd C, 57.56; H, 5.57; N,
5.16%. Found: C, 57.84; H, 5.65; N, 5.24%.
3.2.11. N,N-Bis(2-methoxyethyl)-3-[3-(difluoromethyl)-4-methoxyphenyl]-(E)-propenamide (11i)
A solution of Deoxofluor® 50% in toluene (0.107 mL, 0.435 mmol) was added dropwise to a
suspension of 0.030 g of 3-formyl-4-methoxycinnamic acid (9, 0.030 g, 0.145 mmol) in 0.4 mL of dry
dichloromethane under an argon atmosphere. The reaction mixture was stirred for 45 min at room
temperature. Triethylamine (0.061 mL, 0.435 mmol) was added and the mixture was subsequently
stirred for 1 h at room temperature. The solution was diluted with 10 mL of dichloromethane, washed
twice with 1M HCl and once with water, dried with anhydrous sodium sulfate, and the solvent
evaporated. The resulting solid was purified by flash column chromatography eluting with mixtures
of ethyl acetate–hexane of increasing polarity to give 11i as a crystalline white solid (0.042 g, 84%);
m.p. 60–61 ◦C; 1H-NMR (CDCl3)
(m, 1H, 60-H), 6.93 (t, J = 55.5 Hz, 1H, CF2
3.90 (s, 3H, C 3OAr), 3.72 (t, J = 5.8 Hz, 2H, NC
2H, CH3OC 2), 3.56 (t, J = 5.8 Hz, 2H, CH3OC
13C-NMR (CDCl3) : 167.0 (1-C), 158.3 (t, JCF = 5.60 Hz, 40-C), 141.3 (3-C), 132.3 (t, JCF = 2.05 Hz, 60-C),
128.4 (10-C), 125.3 (t, JCF = 5.8 Hz, 20-C), 123.2 (t, JCF = 22.1 Hz, 30-C), 117.0 (2-C), 111.4 (t, JCF = 236.2
Hz, 2, CH3O H2), 59.3 and 59.0 ( H3OCH2), 56.0 ( H3OAr), 49.2 and
F2H), 111.3 (50-C), 71.4 (
47.5 (N
H2). EIMS m/z (%): 344 (5.4, M + 1), 343 (3.2, M+), 211 (100), 183 (9), 132 (3). Analysis for
δ
: 7.76–7.71 (m, 1H, 20-H), 7.64 (d, J = 15.4 Hz, 1H, 3-H), 7.58–7.52
), 6.95–6.91 (m, 1H, 50-H), 6.89 (d, J = 15.4 Hz, 1H, 2-H),
2), 3.68 (t, J = 5.3 Hz, 2H, NC 2), 3.59 (t, J = 5.4 Hz,
2), 3.35 (s, 3H, C 3OCH2), 3.34 (s, 3H, C 3OCH2);
H
H
H
H
H
H
H
H
δ
C
×
C
C
C
C
C17H23F2NO4: Calcd C, 59.46; H, 6.75; N, 4.08%. Found: C, 59.08; H, 6.55; N, 4.10%.
3.2.12. (E)-3-[3-(Difluoromethyl)-4-methoxyphenyl]-1-(morpholin-4-yl)propenone (11j)
Compound 11j was prepared from acid
9
(30.0 mg, 0.145 mmol), Deoxofluor® 50% in toluene
(0.107 mL, 0.435 mmol), morpholine (0.0376 mL, 0.435 mmol), and triethylamine (0.061 mL, 0.435 mmol)
following the procedure used for 11b. Compound 11j was obtained as a crystalline white solid (0.024
g, 56%); m.p. 120–121 ◦C; 1H-NMR (CDCl3) : 7.82–7.75 (m, 1H, 20-H), 7.68 (d, J = 15.4 Hz, 1H, 3-H),
δ
7.56–7.54 (m, 1H, 60-H), 6.95 (t, J = 55.5 Hz, 1H, CF2
2-H), 3.91 (s, 3H, C
3O), 3.79–3.66 (m, 8H, 200-H, 300-H, 500-H and 600-H); 13C-NMR (CDCl3)
(1-C), 158.4 (t, JCF = 5.7 Hz, 40-C), 142.2 (3-C), 132.7 (60-C), 128.0 (10-C), 124.9 (t, JCF = 5.8 Hz, 20-C),
123.3 (t, JCF = 22.2 Hz, 30-C), 115.4 (2-C), 111.3 (t, JCF = 237.0 Hz, F2H), 111.3 (50-C), 67.0 (200-C and
H
), 6.95–6.93 (m, 1H, 50-H), 6.78 (d, J = 15.4 Hz, 1H,
H
δ
: 165.7
C